Current Ratio of Applied Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Applied Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 30 Sep 2019 to 30 Sep 2025.
- Applied Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 2.12x, a 50% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Applied Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q3 2025 | 2.12x | +0.71x | +50% | 30 Sep 2025 |
| Q2 2025 | 1.71x | +0.29x | +20% | 30 Jun 2025 |
| Q1 2025 | 1.85x | +0.72x | +63% | 31 Mar 2025 |
| Q4 2024 | 1.76x | +0.93x | +113% | 31 Dec 2024 |
| Q3 2024 | 1.41x | +0.51x | +56% | 30 Sep 2024 |
| Q2 2024 | 1.42x | +0.39x | +38% | 30 Jun 2024 |
| Q1 2024 | 1.14x | -0.07x | -5.8% | 31 Mar 2024 |
| Q4 2023 | 0.82x | -0.69x | -46% | 31 Dec 2023 |
| Q3 2023 | 0.91x | -1.03x | -53% | 30 Sep 2023 |
| Q2 2023 | 1.03x | -1.61x | -61% | 30 Jun 2023 |
| Q1 2023 | 1.21x | -2.72x | -69% | 31 Mar 2023 |
| Q4 2022 | 1.52x | -3.41x | -69% | 31 Dec 2022 |
| Q3 2022 | 1.94x | -3.41x | -64% | 30 Sep 2022 |
| Q2 2022 | 2.63x | -3.43x | -57% | 30 Jun 2022 |
| Q1 2022 | 3.93x | -2.65x | -40% | 31 Mar 2022 |
| Q4 2021 | 4.93x | -2.86x | -37% | 31 Dec 2021 |
| Q3 2021 | 5.35x | -2.42x | -31% | 30 Sep 2021 |
| Q2 2021 | 6.07x | -2.18x | -26% | 30 Jun 2021 |
| Q1 2021 | 6.57x | -1.62x | -20% | 31 Mar 2021 |
| Q4 2020 | 7.78x | +3.43x | +79% | 31 Dec 2020 |
| Q3 2020 | 7.77x | +2.74x | +55% | 30 Sep 2020 |
| Q2 2020 | 8.25x | 30 Jun 2020 | ||
| Q1 2020 | 8.19x | 31 Mar 2020 | ||
| Q4 2019 | 4.35x | 31 Dec 2019 | ||
| Q3 2019 | 5.03x | 30 Sep 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.